Medication use in adults with Attention Deficit/Hyperactivity Disorder in a commercially-insured population in the United States.

CONCLUSIONS: There is significant treatment heterogeneity among US adults with ADHD. A sizeable proportion of patients received monotherapies at above the recommended dosages or combination therapies, suggesting existing single-tablet regimens may not meet patients' needs. PMID: 29186993 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research